Rick Kilcoyne by CMK SELECT CMK SELECT CMK SELECT
CMK SELECT CMK SELECT CMK SELECT
Rick Kilcoyne, Managing Partner and Co-Founder of CMK Select, is dedicated to providing innovative solutions with a focus on client satisfaction. Rick has more than 35 years of experience within the life sciences industry, which – combined with his commitment to success – has helped shape the firm’s reputation as a leader in consulting services.
CMK SELECT
43 Route 46 East, Suite 705 Pine Brook, NJ 07058 USA
Rachel Phone: (973) 244-6060

FORGOT YOUR DETAILS?

Rick

Rick Kilcoyne

Managing Partner

Rick Kilcoyne, Managing Partner and Co-Founder of CMK Select, is dedicated to providing innovative solutions with a focus on client satisfaction. Rick has more than 35 years of experience within the life sciences industry, which – combined with his commitment to success – has helped shape the firm’s reputation as a leader in consulting services.

Prior to co-founding CMK Select in 2006, Rick founded both an affiliate organization called Carter McKenzie, as well as the former Livingston Group. Both of these organizations have provided consulting and staffing services to Fortune 500 companies since 1985.

 

EDUCATION:

B.A. in Geoscience from New Jersey State University

PERSONAL FACT:

He is an avid runner and boating enthusiast, as well as an active volunteer and fundraiser for several environmental, ecological, and social organizations. Rick enjoys spending time with his wife and children and entertaining friends at his Jersey Shore home.

... KNOWLEDGE & INSIGHTS

CMK SELECT

Operations Management  

AUTHOR: CMK SELECT

A reputable pharmaceutical company was experiencing a period of high employee turnover in one of its central departments and did not have a tangible on-boarding system in place to help transition its new hires into their respective roles.…
CONTINUE READING
N. Borinshteyn

The Rising Value of Medical Affairs – Engagement with External Stakeholders (KOLs, TLs, EEs)

AUTHOR: N. Borinshteyn

The ever-evolving relationship between the pharmaceutical industry and its key opinion leaders (KOLs) has been a hot topic for a while, and there are several reasons for that: Recent innovative medicines are so complex that many consumers can’t understand them…
CONTINUE READING

LIKE OUR PAGE

FOLLOW US

GET LINKED IN

TOP